Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4254]

SABCS 2022: Camizestrant may be superior to fulvestrant in hormone receptor-positive, HER2-negative breast cancer

SABCS 2022: Camizestrant may be superior to fulvestrant in hormone receptor-positive, HER2-negative breast cancer

SABCS 2022: Genetic profiling may identify patients with breast cancer who can safely omit radiation therapy after breast-conserving surgery

SABCS 2022: Genetic profiling may identify patients with breast cancer who can safely omit radiation therapy after...

SABCS 2022: The TAILORx trial in over 10,000 women with early breast cancer reaches 12 years of recurrence and survival outcomes

SABCS 2022: The TAILORx trial in over 10,000 women with early breast cancer reaches 12 years of recurrence and...

SABCS 2022: Treatment decision guided by CTC count may improve long-term outcomes for mBC

SABCS 2022: Treatment decision guided by CTC count may improve long-term outcomes for mBC

SABCS 2022: Adding capivasertib to fulvestrant improves progression-free survival in patients with advanced hormone receptor-positive breast cancer

SABCS 2022: Adding capivasertib to fulvestrant improves progression-free survival in patients with advanced...

SABCS 2022: Neoadjuvant trastuzumab deruxtecan shows clinical activity in patients with HER2-low breast cancer

SABCS 2022: Neoadjuvant trastuzumab deruxtecan shows clinical activity in patients with HER2-low breast cancer

SABCS 2022: T-DXd yields longer overall survival than T-DM1 in patients with HER2-positive metastatic breast cancer

SABCS 2022: T-DXd yields longer overall survival than T-DM1 in patients with HER2-positive metastatic breast cancer

SABCS 2022: First-line ribociclib plus endocrine therapy may be more effective than combination chemotherapy in patients with aggressive breast cancer

SABCS 2022: First-line ribociclib plus endocrine therapy may be more effective than combination chemotherapy in...

Hospital parking fees contribute to financial toxicity for cancer patients

Hospital parking fees contribute to financial toxicity for cancer patients

SABCS 2022: A genomic assay may predict long-term prognosis in premenopausal patients with hormone receptor-positive early-stage breast cancer

SABCS 2022: A genomic assay may predict long-term prognosis in premenopausal patients with hormone receptor...

More from ecancer